glp-1 intracranial hypertension glp 1 and iih The effect of agonist on idiopathic hypertension: a systematic review meta-analysis Infographic: Landmark trials in Neuro-Ophthalmology—results – GLP-1 Medications: A New Hope

Maintaining a high ratio of GSH to GSSG is essential for cell health and overall well-being

The co-occurrence of genomic NF1 alterations and PRC2 complex inactivating mutations has been observed in melanoma and glioblastoma

CagriSema is further along in the approval processNovo Nordisk submitted it to the FDA in December 2025but cagrilintide itself has its own clinical program

To provide better access to these products, PBMs should remove step therapy requirements from both drugs so patients and prescribers have easier access and increase use of SGLT2 therapies, which are generally less expensive but efficacious

The purchaser assumes full responsibility for handling, use, and regulatory compliance.